G80S (p.Gly80Ser) variant of GCK (Hexokinase-4)

G80S (p.Gly80Ser) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes published literature and structural context.

G80S (p.Gly80Ser) variant details